MaxCyte, Inc. (MXCT)
MXCT Stock Price Chart
Explore MaxCyte, Inc. interactive price chart. Choose custom timeframes to analyze MXCT price movements and trends.
MXCT Company Profile
Discover essential business fundamentals and corporate details for MaxCyte, Inc. (MXCT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Jul 2021
Employees
114.00
Website
https://maxcyte.comCEO
Maher Masoud
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
MXCT Financial Timeline
Browse a chronological timeline of MaxCyte, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.11, while revenue estimate is $8.37M.
Earnings released on 6 Aug 2025
EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%, while revenue for the quarter reached $8.51M , missing expectations by -17.89%.
Earnings released on 7 May 2025
EPS came in at -$0.10 matching the estimated -$0.10, while revenue for the quarter reached $10.39M , beating expectations by +8.59%.
Earnings released on 11 Mar 2025
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $8.69M , missing expectations by -6.24%.
Earnings released on 6 Nov 2024
EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%, while revenue for the quarter reached $8.16M , beating expectations by +6.49%.
Earnings released on 6 Aug 2024
EPS came in at -$0.09 surpassing the estimated -$0.14 by +35.71%, while revenue for the quarter reached $10.43M , beating expectations by +41.51%.
Earnings released on 7 May 2024
EPS came in at -$0.09 surpassing the estimated -$0.14 by +35.71%, while revenue for the quarter reached $11.34M , beating expectations by +52.04%.
Earnings released on 12 Mar 2024
EPS came in at -$0.05 surpassing the estimated -$0.10 by +50.00%, while revenue for the quarter reached $15.67M , beating expectations by +19.68%.
Earnings released on 8 Nov 2023
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%, while revenue for the quarter reached $8.00M , missing expectations by -14.94%.
Earnings released on 9 Aug 2023
EPS came in at -$0.10 matching the estimated -$0.10, while revenue for the quarter reached $9.04M , missing expectations by -16.27%.
Earnings released on 10 May 2023
EPS came in at -$0.11 matching the estimated -$0.11, while revenue for the quarter reached $8.58M , missing expectations by -20.52%.
Earnings released on 15 Mar 2023
EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%, while revenue for the quarter reached $12.42M , beating expectations by +49.32%.
Earnings released on 9 Nov 2022
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%, while revenue for the quarter reached $10.64M , beating expectations by +2.04%.
Earnings released on 10 Aug 2022
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $9.61M , beating expectations by +4.09%.
Earnings released on 9 May 2022
EPS came in at -$0.04 surpassing the estimated -$0.07 by +42.86%, while revenue for the quarter reached $11.59M , beating expectations by +36.97%.
Earnings released on 22 Mar 2022
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $10.15M , beating expectations by +6.17%.
Earnings released on 10 Nov 2021
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $10.14M , missing expectations by -20.63%.
Earnings released on 13 Sept 2021
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $7.11M .
Earnings released on 30 Jul 2021
EPS came in at -$0.09 , while revenue for the quarter reached $6.49M .
Earnings released on 31 Dec 2020
EPS came in at -$0.03 , while revenue for the quarter reached $8.51M .
Earnings released on 30 Sept 2020
EPS came in at -$0.04 , while revenue for the quarter reached $6.76M .
MXCT Stock Performance
Access detailed MXCT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.